Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human FGF-23 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 2604FG025/CF

 View more versions of this product

Catalog No. 2604FG025CF

Add to Cart
This item is not returnable. View return policy



The Recombinant Human FGF-23 Protein is derived from NS0. The Recombinant Human FGF-23 Protein has been validated for the following applications: Bioactivity.


Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 EDTA and DTT.
26.1 kDa
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 3 months, 2 to 8° C under sterile conditions after reconstitution.
95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Mouse myeloma cell line,NS0-derived human FGF-23 protein Tyr25-Ile251 (Arg179Gln),with a C-terminal 6-His tag
<0.1 EU per 1μg of the protein by the LAL method.
Product Suggestions

Product Suggestions



Product Certifications


Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit